K T Rama Rao unveils BE's 300 Crore plant at Hyderabad


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ K T Rama Rao unveils BEs 300 Crore plant at Hyderabad
Hyderabad based pharmaceutical co. Biological E Ltd.recently launched its new plant of Rs.300 crores at Genome Valley. This initiative will enhance the production and manufacture of new vaccines.

Pharmaceutical company Biological E. Limited on 17.02.2020 launched its new plant, built with an investment of Rs. 300 crore at Genome Valley here.Telangana's Industry Minister K.T. Rama Rao inaugurated the facility, which will generate employment for about 1,000 people.

Mahima Datla, Managing Director, Biological E. Limited, this new facility will help their existing vaccines plant enhance the production and manufacture new products, which are in the pipeline.The plant has come up on 29 acres in the Special Economic Zone at Genome Valley in Kolthur village on the outskirts of Hyderabad.

Kiran Mazumdar Shaw, Chairperson and Managing Director, Biocon, Professor Baron Peter Piot, Director, London School of Hygiene and Tropical Medicine were also present.

Rao said the government was committed to make Telangana number one state in terms of industrial growth and employment generation with a special focus on life sciences.Rama Rao also unveiled BE's Typhoid Conjugate Vaccine. Recently, BE received the authorisation from the health regulatory authorities of India to license and market TCV.

TCV is an injectable single-dose vaccine to be administered to children of the age of above 6 months as well as adults. The clinical studies conducted in India demonstrated that the safety and immunogenicity profiles of this vaccine are comparable to the other licensed and WHO Pre-qualified Typhoid conjugate vaccine, Biological E. said.

This vaccine was developed in partnership with the GSK Vaccines Institute for Global Health, based in Siena (Italy), which first developed the asset and transferred it to BE in 2013. Subsequent developmental work on the vaccine was done by BE, including manufacturing process optimization and scale up, pre-clinical studies and full clinical trials in India.

This vaccine will be manufactured in BE's GMP manufacturing facilities in Hyderabad, India and could be commercially available within 3 months, it added.

Story Source : IANS

Tags : #Ktramarao #Hyderabadbasedbiologicaleltd #Typhoidconjugatevaccine #Gskvaccineinstitute

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026